Edward Morrow Atkinson III, EVP, Chief Technical Ops. Off: Vertex Pharmaceuticals VRTX Sell · Filed 24/02/23

Trade details

Type: Insider sale
Amount: $506,545.77
Shares · price: 1,201 sh · $421.77 a share
Held after: 18,509 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Trade date: 24/02/21
Filed: 24/02/23
Days to filing: 2 days

Sold 6.1% of holdings

Share of holding sold: 6.1%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/22~24/03/22

Edward Morrow Atkinson III's recent trades

Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/26
Traded 02/25
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/25
Traded 02/25
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$994.1K
2,031 sh
$994.1K
Filed 02/19
Traded 02/17
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$387K
817 sh
$387K
Filed 02/19
Traded 02/18
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$387K
817 sh
$387K
Filed 02/18
Traded 02/18